In fact, the IDH1 inhibitor AG-120 has been investigated in clinical studies with promising results.31 In addition, we found that a combination of AHA1 and IDH1 expression in osteosarcoma patients can also predict the prognosis. Here, IDH1 is linked to osteosarcoma.